基本信息
浏览量:3
职业迁徙
个人简介
Dr. Badros has extensive clinical experience in Bone Marrow Transplantation with special interest in multiple myeloma. He was involved in the initial trails of thalidomide and has conducted many clinical trials for treatment of relapsed and refractory multiple myeloma. Dr. Badros research has focused on evaluation of immunological approaches to eradicate residual myeloma cells in the high-risk setting following autologous stem cell transplantation using natural killer (NK) and interleukin -2 (IL-2) activated cells and non-myeloablative allogeneic donor grafts.
研究兴趣
论文共 353 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yamini K. Kathari,Haroon Ahmad,Michael E. Kallen,Rima Koka,Destiny Omili,Thierry Iraguha, Jean Clement, Lily Pham, Mazhar Khalid,Xiaoxuan Fan,Etse Gebru,Patricia Lesho,
Transplantation and Cellular Therapyno. 2 (2024): S322
British journal of haematology (2024)
Mehmet Kocoglu,Aaron P. Rapoport,Etse Gebru,Destiny Omili, Daniel Yamoah, Rediet Mulatu,Jean Yared,Nancy M. Hardy,Michael Kallen,Ashraf Z. Badros,Djordje Atanackovic
Cancer Researchno. 6_Supplement (2024): 3616-3616
BLOOD CANCER JOURNALno. 1 (2023): 1-8
The Lancet. Oncologyno. 7 (2023): E293-E311
Ashraf Z. Badros, Thea Nash, Christopher Lawrance, Brandon Tittle,Sunita Philip,Sarah Sunshine,Wuqaas Munir,Xiaoxuan Fan, Christina Ide,Djordje Atanackovic
BLOOD (2023): 6723
Blood (2023): 1973
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn